Banking disruptor SoFi Technologies (SOFI 1.44%) has grown at an impressive pace in roughly four years since it became a publicly traded company. The company's membership base has more than tripled since the end of 2021, SoFi's banking platform has grown from zero at the start of 2022 to more than $27 billion in consumer deposits today, and its adjusted EBITDA in 2024 was about 23 times what it was just three years prior. Even after this fantastic growth, SoFi remains a relatively small financial institutio ...

Root, Inc. (ROOT) is expected to register an improvement in its top and bottom lines when it reports first-quarter 2025 results on May 7, after the closing bell.The Zacks Consensus Estimate for ROOT’s first-quarter revenues is pegged at $305 million, indicating 19.6% growth from the year-ago reported figure.The consensus estimate for earnings is pegged at 45 cents per share. The Zacks Consensus Estimate for ROOT’s first-quarter earnings has moved up 36.4% in the past 30 days. The estimate suggests a year-ov ...

We expect Novavax (NVAX) to surpass expectations when it reports first-quarter 2025 earnings on May 8, before the opening bell. The company’s earnings beat estimates by 32% in the last reported quarter.The Zacks Consensus Estimate for sales is pegged at $71.84 million, while that for earnings is pinned at 19 cents per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar)Factors Shaping NVAX’s Upcoming ResultsStarting this year, pharma giant Sanofi (SNY) acquired exclusive rights to ...

Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -13.64%. A quarter ago, it was expected that this biotechnology company would post a loss of $0.36 per share when it actually produced a loss of $0.53, delivering a surprise of -47.22%.Over the last four quarters ...

Ares Management (ARES) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.80 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.96%. A quarter ago, it was expected that this private equity firm would post earnings of $1.29 per share when it actually produced earnings of $1.23, delivering a surprise of -4.65%.Over the last four quarters, ...

I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking AlphaAnalyst’s Disclosure: I/we have a beneficial long position in the shares of RITM either ...

Since the trade wars initially began in late February, theTrade policy changes seemingly every day. Market volatility has spiked. And recession odds have crept uncomfortably high.These are turbulent times to be an investor.Join Now to Access Our Top Picks for April 2025!Your timing is perfect! We’ve just released our latest top investment picks, and by joining today, you’ll gain immediate access to these exciting opportunities.We invest thousands of hours and over $100,000 annually into researching the most ...

Investor based in Geneva, Switzerland. Follow me on Twitter @GenevaInvestor for daily macro & investing nuggets. I write about macroeconomics, global trends, and what I believe are asymmetric investment opportunities in the market. I have a Master's degree in Business Management. I am currently bullish on PLTR, US equities, Bitcoin. Friend "Rex Investing" is also a contributor to Seeking Alpha. Check out our Podcast: ‘Stock Market Lube’, available on Spotify.All opinions and analysis on SA are exclusively m ...

Super Micro Computer TodaySMCISuper Micro Computer$33.71 +0.98 (+2.99%) 52-Week Range$17.25▼$101.40P/E Ratio16.92Price Target$48.73Add to WatchlistShares of Super Micro Computer Inc. NASDAQ: SMCI have been on a roller coaster of a ride over the past 12 months, swinging by triple-digit percentage points due to company-specific speculation and industry-wide uncertainties impacting future expectations of the business fundamentals. Some of these uncertainties have been cleared, while others seem to still have ...

I rate Cytek Biosciences (NASDAQ: CTKB ) with a Buy rating. I think the net losses that the company has reported since mid-2022 do not correspond with the 79.82% plunge in its stock price. Cytek hasDaniel Mellado is an economist from Carabobo University with a Master's Degree in Statistics from Simon Bolivar University, both obtained in Venezuela.Daniel worked analyzing the agricultural commodity market and the financial investment portfolio for an agribusiness group. Then, he managed two teams, one in trad ...